Open access · CC-BY
via OpenAlex
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?
Francesca Marini, Luisella Cianferotti, Maria Luisa Brandi
International Journal of Molecular Sciences · 2016 · ▲ 121 citations
Abstract
Osteoporosis is a complex multifactorial disorder of the skeleton. Genetic factors are important in determining peak bone mass and structure, as well as the predisposition to bone deterioration and fragility fractures. Nonetheless, genetic factors alone are not sufficient to explain osteoporosis development and fragility fracture occurrence. Indeed, epigenetic factors, representing a link between individual genetic aspects and environmental influences, are also strongly suspected to be involved in bone biology and osteoporosis. Recently, alterations in epigenetic mechanisms and their activity have been associated with aging. Also, bone metabolism has been demonstrated to be under the control of epigenetic mechanisms. Runt-related transcription factor 2 (RUNX2), the master transcription factor of osteoblast differentiation, has been shown to be regulated by histone deacetylases and microRNAs (miRNAs). Some miRNAs were also proven to have key roles in the regulation of Wnt signalling in osteoblastogenesis, and to be important for the positive or negative regulation of both osteoblast and osteoclast differentiation. Exogenous and environmental stimuli, influencing the functionality of epigenetic mechanisms involved in the regulation of bone metabolism, may contribute to the development of osteoporosis and other bone disorders, in synergy with genetic determinants. The progressive understanding of roles of epigenetic mechanisms in normal bone metabolism and in multifactorial bone disorders will be very helpful for a better comprehension of disease pathogenesis and translation of this information into clinical practice. A deep understanding of these mechanisms could help in the future tailoring of proper individual treatments, according to precision medicine's principles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms17081329
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Marini, F., Cianferotti, L., & Brandi, M.L. (2016). Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms17081329
Vancouver
Marini F, Cianferotti L, Brandi ML. Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?. International Journal of Molecular Sciences. 2016. doi:10.3390/ijms17081329.
BibTeX
@article{francesca2016Epigen,
title = {Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?},
author = {Francesca Marini and Luisella Cianferotti and Maria Luisa Brandi},
journal = {International Journal of Molecular Sciences},
year = {2016},
doi = {10.3390/ijms17081329},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Clinical Practice Rheumatology 2006
Citation only
Mechanisms of Disease: is osteoporosis the obesity of bone?
International journal of molecular medicine 2026
Open access · OA
Hormonal remodeling and molecular mechanisms in postmenopausal osteoporosis: Pathogenesis and therapeutic implications (Review).
四川大学学报:医学版 2026
Open access · CC-BY
Research Advances on Mechanisms and Interventions of DNA Methylation-Regulated Aging-Related Imbalance in Bone Metabolism
Springer eBooks 2018
Citation only
The Relationship of Peak Bone Mass, Aging, and Bone Loss to Osteoporosis and Fragility Fractures
Elsevier eBooks 2019
Preprint · CC-BY
Aging Bone, Osteoporosis and Fragility Fracture
Kobe University Repository Kernel (Kobe University) 1984
Preprint